Julia Katherine Rohr, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rural Population | 14 | 2024 | 2321 | 1.290 |
Why?
|
Contraception | 6 | 2024 | 360 | 1.170 |
Why?
|
Family Planning Services | 5 | 2024 | 277 | 1.070 |
Why?
|
South Africa | 23 | 2024 | 1875 | 1.020 |
Why?
|
HIV Infections | 21 | 2024 | 17536 | 0.890 |
Why?
|
Viral Load | 8 | 2024 | 3385 | 0.790 |
Why?
|
Contraceptive Agents | 4 | 2024 | 147 | 0.700 |
Why?
|
Anti-HIV Agents | 9 | 2024 | 4562 | 0.660 |
Why?
|
Disclosure | 2 | 2022 | 755 | 0.630 |
Why?
|
Case Management | 1 | 2019 | 276 | 0.570 |
Why?
|
Antiretroviral Therapy, Highly Active | 5 | 2019 | 1900 | 0.570 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2018 | 618 | 0.470 |
Why?
|
Drug Substitution | 1 | 2016 | 292 | 0.440 |
Why?
|
Self Report | 5 | 2023 | 3771 | 0.430 |
Why?
|
Tanzania | 5 | 2024 | 1406 | 0.430 |
Why?
|
Salvage Therapy | 1 | 2018 | 1274 | 0.370 |
Why?
|
Contraception Behavior | 3 | 2021 | 185 | 0.370 |
Why?
|
Patient Compliance | 2 | 2016 | 2694 | 0.320 |
Why?
|
Social Stigma | 3 | 2024 | 788 | 0.270 |
Why?
|
Longitudinal Studies | 13 | 2024 | 14762 | 0.260 |
Why?
|
Anti-Retroviral Agents | 5 | 2019 | 1787 | 0.250 |
Why?
|
CD4 Lymphocyte Count | 5 | 2018 | 2586 | 0.240 |
Why?
|
Intrauterine Devices | 2 | 2021 | 115 | 0.190 |
Why?
|
Contraceptive Devices | 1 | 2020 | 25 | 0.180 |
Why?
|
Turkey | 4 | 2021 | 256 | 0.170 |
Why?
|
Prevalence | 10 | 2023 | 15835 | 0.170 |
Why?
|
Cohort Studies | 13 | 2024 | 41710 | 0.170 |
Why?
|
Postpartum Period | 2 | 2024 | 1195 | 0.160 |
Why?
|
Fertility | 1 | 2024 | 770 | 0.160 |
Why?
|
Female | 36 | 2024 | 396520 | 0.160 |
Why?
|
Marriage | 1 | 2021 | 351 | 0.160 |
Why?
|
Adult | 30 | 2024 | 223307 | 0.160 |
Why?
|
Cognition | 3 | 2024 | 7057 | 0.160 |
Why?
|
Life Expectancy | 2 | 2023 | 1249 | 0.160 |
Why?
|
Multicenter Studies as Topic | 1 | 2024 | 1733 | 0.150 |
Why?
|
Safe Sex | 1 | 2018 | 144 | 0.150 |
Why?
|
Aged | 20 | 2024 | 171343 | 0.140 |
Why?
|
Cross-Sectional Studies | 7 | 2024 | 26310 | 0.140 |
Why?
|
Blood Chemical Analysis | 1 | 2019 | 434 | 0.140 |
Why?
|
Zambia | 1 | 2018 | 275 | 0.140 |
Why?
|
Maternal Health Services | 2 | 2020 | 473 | 0.140 |
Why?
|
Sexually Transmitted Diseases | 1 | 2023 | 668 | 0.140 |
Why?
|
Middle Aged | 26 | 2024 | 223257 | 0.140 |
Why?
|
Circumcision, Male | 1 | 2018 | 150 | 0.140 |
Why?
|
Blood | 1 | 2019 | 597 | 0.130 |
Why?
|
Diabetes Mellitus | 4 | 2019 | 5887 | 0.130 |
Why?
|
Health Facilities | 1 | 2021 | 579 | 0.130 |
Why?
|
Male | 26 | 2024 | 364142 | 0.130 |
Why?
|
Community Health Services | 2 | 2020 | 659 | 0.120 |
Why?
|
Hypertension | 4 | 2019 | 8616 | 0.120 |
Why?
|
Interviews as Topic | 2 | 2019 | 2741 | 0.110 |
Why?
|
Physician Assistants | 1 | 2016 | 190 | 0.110 |
Why?
|
Humans | 38 | 2024 | 766766 | 0.110 |
Why?
|
Abortion, Induced | 1 | 2020 | 471 | 0.110 |
Why?
|
Rural Health Services | 1 | 2017 | 393 | 0.110 |
Why?
|
Aged, 80 and over | 7 | 2020 | 59550 | 0.110 |
Why?
|
Treatment Failure | 2 | 2016 | 2659 | 0.100 |
Why?
|
Child, Orphaned | 1 | 2013 | 55 | 0.100 |
Why?
|
Depression | 2 | 2024 | 8228 | 0.100 |
Why?
|
Attitude to Health | 1 | 2021 | 2021 | 0.100 |
Why?
|
Counseling | 1 | 2020 | 1552 | 0.100 |
Why?
|
Zidovudine | 1 | 2013 | 625 | 0.100 |
Why?
|
Work | 1 | 2013 | 195 | 0.100 |
Why?
|
Sexual Behavior | 2 | 2023 | 2192 | 0.090 |
Why?
|
Agriculture | 1 | 2013 | 186 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2024 | 4045 | 0.090 |
Why?
|
Financing, Organized | 1 | 2013 | 202 | 0.090 |
Why?
|
Education, Medical, Continuing | 1 | 2016 | 830 | 0.090 |
Why?
|
Women's Health | 1 | 2021 | 2081 | 0.090 |
Why?
|
Tea | 1 | 2013 | 289 | 0.090 |
Why?
|
Community Networks | 1 | 2013 | 202 | 0.090 |
Why?
|
Data Collection | 1 | 2020 | 3321 | 0.090 |
Why?
|
Employment | 2 | 2014 | 1110 | 0.090 |
Why?
|
Pregnancy | 5 | 2024 | 30237 | 0.080 |
Why?
|
Efficiency | 1 | 2013 | 479 | 0.080 |
Why?
|
Health Personnel | 2 | 2020 | 3384 | 0.080 |
Why?
|
Aging | 3 | 2023 | 8731 | 0.080 |
Why?
|
Child Welfare | 1 | 2013 | 521 | 0.080 |
Why?
|
Young Adult | 10 | 2021 | 59939 | 0.080 |
Why?
|
Kenya | 3 | 2018 | 759 | 0.070 |
Why?
|
Health Status | 2 | 2020 | 4087 | 0.070 |
Why?
|
Adenine | 1 | 2013 | 993 | 0.070 |
Why?
|
HIV Seropositivity | 1 | 2013 | 962 | 0.070 |
Why?
|
Vulnerable Populations | 1 | 2013 | 718 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 2 | 2019 | 3230 | 0.070 |
Why?
|
Psychometrics | 1 | 2016 | 3060 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2024 | 10384 | 0.070 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2018 | 2184 | 0.070 |
Why?
|
Ambulatory Care | 1 | 2016 | 2779 | 0.060 |
Why?
|
Poverty | 1 | 2016 | 2714 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2013 | 2205 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39309 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2016 | 4410 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7119 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5514 | 0.050 |
Why?
|
Adolescent | 7 | 2021 | 88904 | 0.050 |
Why?
|
Sleep | 1 | 2018 | 4815 | 0.050 |
Why?
|
Hospitals | 1 | 2016 | 3888 | 0.050 |
Why?
|
Time Factors | 4 | 2018 | 40149 | 0.050 |
Why?
|
Family Characteristics | 2 | 2021 | 1002 | 0.050 |
Why?
|
Sex Factors | 3 | 2024 | 10619 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12534 | 0.050 |
Why?
|
Mass Screening | 1 | 2016 | 5454 | 0.040 |
Why?
|
Caregivers | 1 | 2013 | 2303 | 0.040 |
Why?
|
Pregnancy, Unplanned | 1 | 2021 | 85 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2018 | 65273 | 0.040 |
Why?
|
Primary Health Care | 1 | 2016 | 4735 | 0.040 |
Why?
|
Pakistan | 1 | 2020 | 300 | 0.040 |
Why?
|
Comorbidity | 3 | 2019 | 10580 | 0.040 |
Why?
|
Nepal | 1 | 2020 | 302 | 0.040 |
Why?
|
Comparative Effectiveness Research | 1 | 2023 | 713 | 0.040 |
Why?
|
Lamivudine | 1 | 2019 | 367 | 0.040 |
Why?
|
Telomere | 1 | 2023 | 943 | 0.040 |
Why?
|
Postnatal Care | 1 | 2020 | 273 | 0.040 |
Why?
|
Age Factors | 3 | 2019 | 18397 | 0.040 |
Why?
|
Program Evaluation | 2 | 2017 | 2504 | 0.030 |
Why?
|
Body Weights and Measures | 1 | 2017 | 208 | 0.030 |
Why?
|
Urban Population | 1 | 2024 | 2040 | 0.030 |
Why?
|
Cognitive Reserve | 1 | 2016 | 92 | 0.030 |
Why?
|
Vietnam | 1 | 2016 | 413 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2017 | 521 | 0.030 |
Why?
|
Probability | 1 | 2020 | 2476 | 0.030 |
Why?
|
Public Sector | 1 | 2016 | 265 | 0.030 |
Why?
|
Culture | 1 | 2018 | 622 | 0.030 |
Why?
|
Minority Groups | 1 | 2021 | 1208 | 0.030 |
Why?
|
Income | 2 | 2013 | 1875 | 0.030 |
Why?
|
Stavudine | 1 | 2013 | 85 | 0.030 |
Why?
|
Sexual Partners | 1 | 2018 | 804 | 0.030 |
Why?
|
Blood Glucose | 2 | 2019 | 6422 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2018 | 746 | 0.030 |
Why?
|
Child Health Services | 1 | 2018 | 645 | 0.030 |
Why?
|
Emotions | 1 | 2024 | 2758 | 0.020 |
Why?
|
HIV Antibodies | 1 | 2019 | 1337 | 0.020 |
Why?
|
Blood Pressure | 2 | 2019 | 8533 | 0.020 |
Why?
|
Quality of Life | 1 | 2014 | 13476 | 0.020 |
Why?
|
Retreatment | 1 | 2013 | 598 | 0.020 |
Why?
|
Organizational Case Studies | 1 | 2013 | 301 | 0.020 |
Why?
|
HIV | 1 | 2018 | 1588 | 0.020 |
Why?
|
Absenteeism | 1 | 2013 | 247 | 0.020 |
Why?
|
Risk Factors | 4 | 2020 | 74881 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15657 | 0.020 |
Why?
|
Ambulatory Care Facilities | 1 | 2016 | 939 | 0.020 |
Why?
|
Educational Measurement | 1 | 2016 | 1259 | 0.020 |
Why?
|
Chronic Disease | 1 | 2024 | 9357 | 0.020 |
Why?
|
Policy Making | 1 | 2013 | 547 | 0.020 |
Why?
|
Qualitative Research | 1 | 2020 | 3138 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1217 | 0.020 |
Why?
|
Overweight | 1 | 2019 | 2446 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2274 | 0.020 |
Why?
|
Food Supply | 1 | 2013 | 544 | 0.020 |
Why?
|
Population Surveillance | 1 | 2017 | 2594 | 0.020 |
Why?
|
Workload | 1 | 2013 | 849 | 0.020 |
Why?
|
Lipids | 1 | 2017 | 3319 | 0.020 |
Why?
|
Educational Status | 1 | 2013 | 2510 | 0.020 |
Why?
|
Health Care Costs | 1 | 2018 | 3242 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2020 | 4056 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2017 | 3853 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14652 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7841 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2013 | 2116 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21525 | 0.010 |
Why?
|
Dementia | 1 | 2016 | 2741 | 0.010 |
Why?
|
HIV-1 | 1 | 2019 | 6948 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20144 | 0.010 |
Why?
|
Infant | 1 | 2018 | 36461 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 81635 | 0.010 |
Why?
|
Child, Preschool | 1 | 2013 | 42577 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 54871 | 0.010 |
Why?
|
Child | 1 | 2013 | 80668 | 0.000 |
Why?
|